"inflammatory breast cancer" OR "inflammatory breast carcinoma"

High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt.

Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Fokuda A, Harford JB, Merajver SD.

Breast J. 2009 Jul-Aug;15(4):432-4. No abstract available.

PMID: 19601951 [PubMed - in process]

Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.

Sportès C, Steinberg SM, Liewehr DJ, Gea-Banacloche J, Danforth DN, Avila DN, Bryant KE, Krumlauf MC, Fowler DH, Pavletic S, Hardy NM, Bishop MR, Gress RE.

Biol Blood Marrow Transplant. 2009 Aug;15(8):963-70.

PMID: 19589486 [PubMed - in process]

Circulating tumor cells in metastatic inflammatory breast cancer.

Mego M, De Giorgi U, Hsu L, Ueno N, Valero V, Jackson S, Andreopoulou E, Kau SW, Reuben JM, Cristofanilli M.

Ann Oncol. 2009 Jun 25. [Epub ahead of print]

PMID: 19556320 [PubMed - as supplied by publisher]

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer.

Manga GP, Shahi PK, Ureña MM, Pereira RQ, Plaza MI, Peron YI, Val RG, Carrión JB, Cañón EP, Alfonso PG.

Breast Cancer. 2009 Jun 24. [Epub ahead of print]

PMID: 19551465 [PubMed - as supplied by publisher]

Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.

Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, Hochman T, Formenti SC, Schneider RJ.

Nat Cell Biol. 2009 Jul;11(7):903-8. Epub 2009 Jun 14.

PMID: 19525934 [PubMed - in process]

Lapatinib for inflammatory breast cancer.

Hall PS, Hanby A, Cameron DA.

Lancet Oncol. 2009 Jun;10(6):538-9. No abstract available.

PMID: 19482243 [PubMed - indexed for MEDLINE]

Molecular targets for treatment of inflammatory breast cancer.

Yamauchi H, Cristofanilli M, Nakamura S, Hortobagyi GN, Ueno NT.

Nat Rev Clin Oncol. 2009 Jul;6(7):387-94. Epub 2009 May 26.

PMID: 19468291 [PubMed - in process]

Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.

Hidar S, Bibi M, Gharbi O, Tebra S, Trabelsi A, Korbi S, Bouaouina N, Ben Ahmed S, Khaïri H.

Int J Surg. 2009 Jun;7(3):272-5. Epub 2009 May 3.

PMID: 19410665 [PubMed - in process]

Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study.

Kaufman B, Trudeau M, Awada A, Blackwell K, Bachelot T, Salazar V, DeSilvio M, Westlund R, Zaks T, Spector N, Johnston S.

Lancet Oncol. 2009 Jun;10(6):581-8. Epub 2009 Apr 24.

PMID: 19394894 [PubMed - indexed for MEDLINE]

10:

Intravascular ALK-positive anaplastic large-cell lymphoma mimicking inflammatory breast carcinoma.

Krishnan C, Moline S, Anders K, Warnke RA.

J Clin Oncol. 2009 May 20;27(15):2563-5. Epub 2009 Apr 13. No abstract available.

PMID: 19364961 [PubMed - indexed for MEDLINE]

11:

cDNA microarray analysis of inflammatory breast cancer signatures.

Laere SJ, Vermeulen PB, Dirix LY.

Methods Mol Biol. 2009;512:71-98.

PMID: 19347274 [PubMed - indexed for MEDLINE]

12:

Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.

Untch M, von Minckwitz G.

Breast Cancer Res. 2009;11(2):203. Epub 2009 Mar 17.

PMID: 19344488 [PubMed - in process]

13:

Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.

Khalifeh I, Deavers MT, Cristofanilli M, Coleman RL, Malpica A, Gilcrease MZ.

Breast J. 2009 Mar-Apr;15(2):176-81.

PMID: 19292804 [PubMed - indexed for MEDLINE]

14:

BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.

Man YG, Schwartz A, Levine PH, Teal C, Berg PE.

Cancer Biomark. 2009;5(1):9-17.

PMID: 19242057 [PubMed - indexed for MEDLINE]

15:

Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.

Zell JA, Tsang WY, Taylor TH, Mehta RS, Anton-Culver H.

Breast Cancer Res. 2009;11(1):R9. Epub 2009 Feb 19.

PMID: 19228416 [PubMed - indexed for MEDLINE]

16:

Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.

Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M.

J Exp Ther Oncol. 2008;7(4):299-312.

PMID: 19227010 [PubMed - indexed for MEDLINE]

17:

Molecular determinants of the inflammatory breast cancer phenotype.

Houchens NW, Merajver SD.

Oncology (Williston Park). 2008 Dec;22(14):1556-61; discussion 1561, 1565-8, 1576.

PMID: 19198217 [PubMed - indexed for MEDLINE]

18:

Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.

Abramowitz MC, Li T, Morrow M, Sigurdson ER, Anderson P, Nicolaou N, Freedman G.

Am J Clin Oncol. 2009 Feb;32(1):30-3.

PMID: 19194121 [PubMed - indexed for MEDLINE]

19:

A comprehensive evaluation of outcomes for inflammatory breast cancer.

Yang R, Cheung MC, Hurley J, Byrne MM, Huang Y, Zimmers TA, Koniaris LG.

Breast Cancer Res Treat. 2009 Jan 24. [Epub ahead of print]

PMID: 19169811 [PubMed - as supplied by publisher]

20:

Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.

Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT.

J Nucl Med. 2009 Feb;50(2):231-8. Epub 2009 Jan 21.

PMID: 19164229 [PubMed - indexed for MEDLINE]

Recent Activity